CClinicalTrials.gg
Status unknownNCT03033628Updated Feb 15, 2017

Pain Perception of Dental Local Anesthesia Using "DentalVibe Comfort System" in a Group of Egyptian Children

An interventional study of injection using DentalVibe comfort system and traditional dental injection in Dental Anxiety, sponsored by Cairo University. Status unknown. Open to participants aged 6 Years to 7 Years, including healthy volunteers. Per ClinicalTrials.gov, last updated 2017-02-15.

Sponsored by Cairo University · Not applicable, Interventional, and Other

The sponsor has not verified this record recently (last verified Feb 2017), so the status shown — last known as Not yet recruiting — may be out of date.
Phase
Not applicable
Study type
Interventional
Enrollment
21
Allocation
Randomized
Ages
6 Years to 7 Years
Sex
All
01

Study summary

The aim of this study is to compare pain during maxillary infiltration local anesthesia injection with the aid of DentalVibe comfort system in comparison to maxillary infiltration injection alone in pediatric dental patients.

Read the detailed description

The aim of this study is to compare pain during maxillary infiltration local anesthesia injection with the aid of DentalVibe comfort system in comparison to maxillary infiltration injection alone.

Intervention:

History taking from the child and the parent including personal, medical and dental history as in the examination sheet (Appendix A) to assess inclusion criteria.

Clinical procedure:

Intervention group:

Clinical examination using mirror and probe to assess inclusion criteria. Before initiating the treatment, the site of the injection will be dried then prepped with antiseptic solution swab, then a topical anaesthetic agent (topical anesthetics 20% benzocaine) will be applied with a cotton tip applicator for 60 sec.

Demonstration will be performed by putting the device into direct contact with the children's nails before applying the device intraorally.

The cheek will be retracted and the device will be turned on.

1mL of local anesthetic solution (articaine hypochloride 4% with 1:100.000 epinephrine, Septodont) will be injected using a 27 gauge needle which will be delivered over 1 min.

Control group:

AS that of the intervention group except, the device will be used only as a cheek retractor during the injection, but will be turned off.

Assessment:

Objective assessment will be performed by observing the patients behavior using the FLAAC scale during the anesthetic injection and needle insertion.

Subjective evaluation will be obtained using the Wong-Baker FACES pain rating scale.

02

Conditions studied

  • Dental Anxiety
03

In context

Lead sponsor

Cairo University is the lead sponsor of 4,780 studies on the registry; 1,427 are open to participants now.

Of its 36 completed or terminated interventional studies of FDA-regulated products, 5 (14%) have results posted.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
6 Years to 7 Years
Sexes eligible
All
Accepts healthy volunteers
Yes

Inclusion criteria

  1. Healthy children aged 6-7 years old.
  2. Apparently healthy Children.
  3. Cooperative children.
  4. Children with carious maxillary bilateral primary molars indicated for extraction.

Exclusion criteria

Exclusion Criteria:

  1. Children who are allergic to amide group.
  2. Children with Neurologic disorders.
  3. Children with mental disability.
  4. Presence of periapical or gingival legion.
  5. Severe Gingivitis.
05

Study design

Phase
Not applicable
Primary purpose
Other
Allocation
Randomized
Intervention model
Crossover assignment
Masking
None (open label)
Enrollment
21 participants (estimated)

Study arms

  • Experimental
    DV group

    Device: injection using DentalVibe comfort system. giving maxillary infiltration dental local anesthesia with the aid of "DentalVibe comfort system" on one side of the maxillary arch prior extraction of primary molar tooth

    Device: injection using DentalVibe comfort system

  • Active comparator
    C group

    Device: traditional dental injection giving maxillary infiltration dental local anesthesia without the aid of "DentalVibe comfort system" on the other side of the maxillary arch prior extraction of primary molar tooth

    Device: traditional dental injection

Interventions

  • Deviceinjection using DentalVibe comfort system

    giving maxillary infiltration injection of dental local anesthesia using DentalVibe comfort system.

  • Devicetraditional dental injection

    giving maxillary infiltration injection of dental local anesthesia without using DentalVibe comfort system.

06

What researchers measure

Primary outcomes

  1. pain during injection

    pain assessment using FLACC behavioral pain assessment (scale 0-10) and Wong-Baker FACES pain rating scale (scale 0-10) e 0: Relaxed and comfortable 1-3: Mild discomfort. 4-6: Moderate pain. 7-10: Severe discomfort or pain or both.

    Time frame: within 1 year

07

Study locations

No study locations are listed for this record.

08

References and documents

Individual participant data

Plan to share: No

No publications or documents are linked to this record.

09

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on Feb 15, 2017, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT03033628
Lead sponsor
Cairo University
Responsible party
Muaaz Marwan halal (principal investigator, Cairo University) — Principal investigator
First posted
Jan 27, 2017
Start date
Apr 1, 2017 (estimated)
Primary completion
Jun 1, 2017 (estimated)
Completion
Jan 1, 2018 (estimated)
Last update
Feb 15, 2017

Study contacts

Muaaz Hilal, DR
Contact
muaaz09@hotmail.com
00201226090374
Norhan El-dokky, PHD
study director · Cairo University

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
Yes
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is status unknown, as verified in Feb 2017. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion